Psychedelic Business Spotlight - January 21

Psychedelic Business Spotlight – January 21

Catch up on some of the biggest psychedelic business developments that unfolded in the last week.
Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary Technology

Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary Technology

The technology may be more broadly used in the future for neuroscientific or physiological studies of brain activity during psychedelic use.
Psychedelic Business Spotlight — January 14

Psychedelic Business Spotlight — January 14

This week in psychedelic business news: Another psychedelics company starts trading on OTCQB; another ketamine trial delivers; and another patent is issued.

Interview with James Lanthier, CEO of Mindset Pharma

,
CEO of Mindset Pharma, James Lanthier, gives us an overview of his company and the 4 new psychedelics they are creating. He also discusses some big breaking news!
Psychedelic Business Spotlight — January 7

Psychedelic Business Spotlight — January 7

This week in psychedelic business news: Mindset Pharma partners with global pharmaceutical company; Awakn Life Sciences explores behavioral addictions; Ei.Ventures buys virtual land for psychedelic therapy.
Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds

Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds

It’s yet another sign that the pharmaceutical industry at large is taking the potential of psychedelics very seriously.

Psychedelic Business Spotlight – December 31

This week in psychedelic business news: Mindset Pharma files another patent for compounds with "perfect microdosing drug profile," and Core One Labs is preparing to capitalize on functional mushroom market.

2021: A Year in Review for the Psychedelics Business

Our resident Psychedelic Investor looks back at some of this growing industry's biggest moments and how they may shape the business in 2022.
Psychedelic Business News Spotlight - December 24

Psychedelic Business Spotlight – December 24

This week in psychedelic business news: FDA green lights a new psilocybin study; MindMed commences LSD treatment for ADHD; Sage Institute shuffles leadership.
Psychedelic Business Spotlight – December 17

Psychedelic Business Spotlight – December 17

This week in psychedelic business news: Cybin steps closer to a new patent; MindMed appoints new CEO; MAPS and Wesana Health resume negotiations.